Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹54Cr
Construction - Civil/Turnkey
Rev Gr TTM
Revenue Growth TTM
41.47%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

CONART
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -25.6 | 53.3 | -12.3 | 71.9 | 61.4 | 14.2 | -9.2 | 2.8 | 58.9 | 49.0 | 53.5 | 10.2 |
| 8 | 8 | 11 | 12 | 12 | 10 | 10 | 14 | 20 | 14 | 15 | 15 |
Operating Profit Operating ProfitCr |
| 10.3 | 2.8 | 7.9 | 11.9 | 11.9 | 2.4 | 2.5 | 1.5 | 10.3 | 3.1 | 9.2 | 6.1 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 0 | 1 | 2 | 2 | 0 | 0 | 0 | 2 | 1 | 2 | 1 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | 40.4 | -61.8 | 187.9 | 103.5 | 75.8 | 130.8 | -62.1 | -81.9 | 7.8 | 140.0 | 258.3 | 190.5 |
| 7.7 | 1.5 | 8.2 | 8.4 | 8.4 | 3.0 | 3.4 | 1.5 | 5.7 | 4.9 | 8.0 | 3.9 |
| 1.1 | 0.2 | 1.2 | 1.8 | 1.8 | 0.5 | 0.6 | 0.3 | 4.0 | 1.1 | 2.1 | 1.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 127.1 | 8.6 | -1.5 | 10.2 | 37.8 | -18.7 | -13.9 | 68.4 | -2.9 | 37.8 | 15.6 | 21.2 |
| 18 | 19 | 19 | 21 | 29 | 24 | 21 | 35 | 33 | 45 | 53 | 63 |
Operating Profit Operating ProfitCr |
| 3.2 | 8.1 | 9.4 | 8.2 | 7.4 | 5.6 | 4.1 | 4.7 | 8.2 | 7.2 | 6.9 | 7.5 |
Other Income Other IncomeCr | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 2 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 |
| 1 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 3 | 3 | 4 | 6 |
| 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 2 |
|
| 1,272.7 | -0.6 | 15.3 | -6.5 | 39.1 | -28.8 | -13.1 | 24.1 | 53.7 | 56.0 | -13.1 | 44.5 |
| 5.9 | 5.4 | 6.3 | 5.3 | 5.4 | 4.7 | 4.8 | 3.5 | 5.6 | 6.3 | 4.7 | 5.7 |
| 1.9 | 1.9 | 2.1 | 1.9 | 2.7 | 1.9 | 1.6 | 2.0 | 3.1 | 4.9 | 4.3 | 8.2 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| 11 | 12 | 13 | 15 | 16 | 17 | 18 | 20 | 22 | 26 | 29 | 30 |
Current Liabilities Current LiabilitiesCr | 3 | 3 | 3 | 4 | 6 | 4 | 4 | 5 | 4 | 5 | 10 | 12 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 9 | 10 | 13 | 16 | 20 | 20 | 21 | 23 | 24 | 27 | 34 | 38 |
Non Current Assets Non Current AssetsCr | 7 | 7 | 6 | 6 | 6 | 5 | 4 | 5 | 6 | 7 | 7 | 8 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 2 | 0 | 0 | 1 | 0 | 2 | 2 | -1 | 4 | 1 | 5 |
Investing Cash Flow Investing Cash FlowCr | 1 | -1 | 0 | -3 | 0 | -3 | -1 | 1 | -2 | -1 | -2 |
Financing Cash Flow Financing Cash FlowCr | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Free Cash Flow Free Cash FlowCr | 2 | -1 | 0 | 1 | -1 | 2 | 2 | -3 | 2 | 1 | 4 |
| 214.9 | -36.4 | 10.9 | 104.0 | -29.3 | 161.9 | 192.1 | -115.2 | 206.1 | 29.7 | 183.5 |
CFO To EBITDA CFO To EBITDA% | 389.5 | -24.2 | 7.3 | 68.0 | -21.2 | 137.0 | 221.4 | -85.3 | 139.4 | 26.0 | 125.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 5 | 8 | 10 | 12 | 9 | 6 | 8 | 10 | 12 | 29 | 44 |
Price To Earnings Price To Earnings | 4.7 | 6.9 | 7.7 | 10.3 | 5.3 | 4.8 | 8.0 | 8.1 | 6.1 | 9.4 | 16.6 |
Price To Sales Price To Sales | 0.3 | 0.4 | 0.5 | 0.6 | 0.3 | 0.2 | 0.4 | 0.3 | 0.3 | 0.6 | 0.8 |
Price To Book Price To Book | 0.4 | 0.5 | 0.6 | 0.7 | 0.5 | 0.3 | 0.4 | 0.5 | 0.5 | 1.0 | 1.4 |
| 0.3 | 2.1 | 3.0 | 5.2 | 3.0 | 3.6 | 7.7 | 5.7 | 3.2 | 7.5 | 9.8 |
Profitability Ratios Profitability Ratios |
| 49.5 | 63.6 | 62.0 | 69.9 | 58.7 | 50.6 | 60.3 | 59.1 | 44.8 | 56.5 | 68.0 |
| 3.2 | 8.1 | 9.4 | 8.2 | 7.4 | 5.6 | 4.1 | 4.7 | 8.2 | 7.2 | 6.9 |
| 5.9 | 5.4 | 6.3 | 5.3 | 5.4 | 4.7 | 4.8 | 3.5 | 5.6 | 6.3 | 4.7 |
| 8.9 | 11.2 | 12.2 | 9.4 | 11.6 | 7.7 | 6.6 | 7.5 | 10.1 | 12.1 | 12.1 |
| 8.3 | 7.6 | 8.1 | 6.8 | 8.6 | 5.8 | 4.8 | 5.6 | 7.8 | 10.6 | 8.3 |
| 6.9 | 6.3 | 6.6 | 5.5 | 6.5 | 4.8 | 4.0 | 4.6 | 6.7 | 9.2 | 6.4 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Conart Engineers Limited is a specialized construction engineering firm with a legacy spanning over **four decades**. The company operates as a **General Contractor** and **Project Management** specialist, primarily serving high-growth private sector industries. Historically rooted in civil and structural works, the company is currently undergoing a strategic evolution to integrate **Information Technology** and **Real Estate** services into its core operational framework.
---
### **Core Operational Framework & Service Portfolio**
Conart operates through an **At-Risk Contracting** model, providing end-to-end infrastructure solutions. While the company is officially classified under a **single business segment (Construction activity)**, its service capabilities are diverse:
* **General Contracting:** Full-scale execution of civil, structural, and architectural works for industrial and commercial clients.
* **Project Management Services (PMS):** Comprehensive oversight, coordination, and technical supervision of construction lifecycles.
* **Industrial Specialization:** A dominant presence in high-specification sectors including **Heavy Machinery, Pharmaceuticals, Chemicals, and Textiles**.
* **Institutional & Residential:** Proven track record in developing educational facilities, commercial complexes, and housing projects.
* **Project Velocity:** In the **FY 2024-25** period, the company successfully completed **seven industrial projects**. It currently maintains an active pipeline of **seven additional projects** scheduled for completion in **2025-26**.
---
### **Strategic Pivot: IT Integration & Geographic Expansion**
The company is transitioning from a traditional builder to a technology-enabled engineering firm. A formal amendment to the **Object Clause** of its Memorandum of Association has paved the way for two new growth pillars:
1. **Construction-Tech Software:** Development of proprietary software solutions designed to enhance operational efficiency, economic performance, and technical implementation within the construction field.
2. **Real Estate & Retail Scaling:** Strategy to scale **margin-accretive products** in **Gurugram, Delhi, and Vadodara**, with planned entries into **Mumbai, Goa, and Chandigarh**. The company specifically aims to **double its retail presence** to capture the luxury mall and quality commercial segments.
---
### **Project Pipeline & Recent Contract Wins**
Conart maintains a strong order book, with a heavy concentration of high-value industrial work in the **Gujarat** region.
| Client | Project Type | Location | Approx. Value | Timeline |
| :--- | :--- | :--- | :--- | :--- |
| **Powerstatic Solutions India** | New Factory Building | Sanand, Gujarat | **₹30.38 Crore** | Active |
| **Apothecon Pharmaceuticals** | Formulation Facility | Vadodara, Gujarat | **₹14.50 Crore** | **11 Months** |
| **Shiva Performance Materials** | Civil Work (Plant-6) | Padra, Vadodara | **₹7.00 Crore** | **12 Months** |
| **Bundy India Limited** | Civil & Structure Work | Vadodara, Gujarat | **₹7.00 Crore** | **6 Months** |
| **Jecon Engineers Pvt Ltd** | Industrial Shed & Utilities | Savli, Vadodara | **₹4.50 Crore** | Active |
| **Amneal Pharmaceuticals** | Warehouse & Softmist Plant | Sanand, Gujarat | **₹3.10 Crore** | Active |
---
### **Financial Performance & Capital Structure**
Conart has demonstrated consistent revenue growth, characterized by a conservative debt profile and a focus on internal accruals.
**Three-Year Financial Summary:**
| Metric (Rs. in Crore) | FY 2024-25 | FY 2023-24 | FY 2022-23 |
| :--- | :---: | :---: | :---: |
| **Gross Sales / Revenue** | **56.53** | **48.89** | **35.49** |
| **Net Profit After Tax (PAT)** | **2.68** | **3.08** | **1.97** |
| **Cash Profit** | **3.21** | **3.68** | **2.52** |
| **Net Worth** | **32.12** | **29.03** | **25.28** |
**Key Financial Observations:**
* **Revenue Growth:** Revenue increased by **15.61%** in FY25, following a significant **37.79%** surge in FY24.
* **Profitability & Margins:** While revenue grew, PAT saw a **13.07%** contraction in FY25 due to rising professional fees, sub-contractor payments, and operational costs.
* **Debt-Free Status:** The company remains **debt-free** regarding long-term bank loans and working capital borrowings. It utilizes **mutual fund investments** to secure bank guarantees rather than relying on credit lines.
* **Liquidity & Working Capital:** The **Current Ratio** remains healthy at **3.56**. The debtor turnover cycle is **61 days**, with **95.50%** of receivables classified as "good."
* **Capital Allocation:** The Board recommended **no dividend** for FY25, opting to **plough back profits** to fund expansion and the **₹3.5 Crore** investment into a Vadodara-based **LLP** for new business avenues.
---
### **Equity & Corporate Governance**
* **Stock Split:** In May 2025, the company subdivided its equity shares from a face value of **₹10** to **₹5**. This increased the total share count from **31,40,000** to **62,80,000** to enhance market liquidity.
* **Authorized Capital:** Currently stands at **₹4,00,00,000** (divided into **80,00,000** shares).
* **Leadership:** **Mr. Jitendra Sura** was re-appointed as Managing Director for a **3-year term** starting November 2024, ensuring management continuity.
* **Compliance:** Financials follow **Ind AS** standards. The company reported **zero** legal complaints and **zero** related-party loans to director-linked firms in the recent period.
---
### **Risk Management & Mitigation**
Conart’s risk profile is centered on commodity volatility and supply chain stability, managed through disciplined procurement.
* **Input Cost Volatility:** Exposure to **Iron & Steel** price fluctuations, rising electricity costs, and freight.
* *Mitigation:* **Advance planning** and sourcing from a diversified base of **reputed domestic suppliers**.
* **Currency Risk:** Exposure arises from imported raw materials.
* *Mitigation:* The company maintains an **active hedging policy** for all foreign exchange exposures.
* **Operational Risks:** Potential for supplier concentration or unfavorable contract renewals.
* *Mitigation:* Strategic geographic concentration in **Mumbai and Vadodara** allows for tighter oversight and localized supply chain resilience.
* **Structural Integrity:** The company has **zero subsidiaries**, eliminating the risks associated with complex corporate structures or subsidiary-level debt.